Symbols

TCMD

Tactile Systems·NASDAQ

--(--)

TCMD fundamentals

TCMD Q4 2025 Earnings

Tactile Systems (TCMD) released its earnings on Feb 17, 2026: revenue was 103.59M (YoY +21.04%), beat estimates; EPS was 0.46 (YoY +15.00%), beat estimates.

Revenue / YoY

103.59M

+21.04%

EPS / YoY

0.46

+15.00%

Report date

Feb 17, 2026

TCMD Earnings Call Summary for Q4,2025

Revenue Momentum: 2025 revenue +12% to $329.5M; Q4 +21% to $103.6M. 2026 guidance $357-365M (+8-11%).
Gross Margin Expansion: Full year 75.9% (+190bps YoY). Q4 78.2% vs 75.2% prior.
Strategic Acquisition: LymphaTech 3D scanning tech to enhance lymphedema assessment accuracy and accelerate therapy access.
Medicare Prior Auth: Short-term headwind in 2026 but manageable with prior auth expertise; 2026 guidance reflects 1-2Q impact.
EBITDA Growth: 2025 adjusted EBITDA $44.8M (+21% YoY). 2026 target $49-51M (13.8-14.0% margin).

Earnings

EPS

Revenue

Revenue & Expenses

TCMD has released its 2025 Q4 earnings report, with revenue of 103.59M, reflecting a YoY change of 21.04%, and net profit of 10.63M, showing a YoY change of 9.45%. The Sankey diagram below clearly presents TCMD's revenue sources and cost distribution.

Key Indicators

Tactile Systems (TCMD) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Tactile Systems (TCMD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Tactile Systems (TCMD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Tactile Systems (TCMD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown